Data gathered: November 22
AI Stock Analysis - Pacific Biosciences of California (PACB)
Analysis generated April 11, 2024. Powered by Chat GPT.
Pacific Biosciences of California, known as PacBio, specializes in developing and manufacturing advanced genomic sequencing technology. Their platform is renowned for its long-read sequencing capability, which allows for a more detailed and comprehensive understanding of genomes and transcriptomes. The company's systems are used by researchers in fields like healthcare, agriculture, and environmental science to advance biological research and provide insights into genetic diseases and traits.
Stock Alerts - Pacific Biosciences of California (PACB)
 |
Pacific Biosciences of California | November 22 Price is up by 5.4% in the last 24h. |
|
Pacific Biosciences of California | November 21 Price is up by 5.8% in the last 24h. |
|
Pacific Biosciences of California | November 19 Price is up by 5.1% in the last 24h. |
|
Pacific Biosciences of California | November 15 Price is down by -7.8% in the last 24h. |
Alternative Data for Pacific Biosciences of California
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 16 | Sign up | Sign up | Sign up |
| Sentiment | 73 | Sign up | Sign up | Sign up |
| Webpage traffic | 89,000 | Sign up | Sign up | Sign up |
| Employee Rating | 54 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | 206 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 2 | Sign up | Sign up | Sign up |
| Facebook Followers | 4,576 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 15 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 14,090 | Sign up | Sign up | Sign up |
| Twitter Followers | 45,634 | Sign up | Sign up | Sign up |
| Twitter Mentions | 21 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 5,690 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 17 | Sign up | Sign up | Sign up |
| Linkedin Employees | 687 | Sign up | Sign up | Sign up |
About Pacific Biosciences of California
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems.
| Price | $1.80 |
| Target Price | Sign up |
| Volume | 8,710,000 |
| Market Cap | $471M |
| Year Range | $1.2 - $3.84 |
| Dividend Yield | 0% |
| Analyst Rating | 43% buy |
| Industry | Medical Devices |
In the news
 |
Pacific Biosciences of California, Inc. (PACB): Among the Best Genomics Stocks to Buy Right NowNovember 19 - Yahoo |
 |
Research Analysts Offer Predictions for PACB FY2024 EarningsNovember 18 - ETF Daily News |
|
Sumitomo Mitsui Trust Group Inc. Cuts Stock Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB)November 18 - ETF Daily News |
|
Pacific Biosciences of California (NASDAQ:PACB) Trading Up 5.3% After Analyst UpgradeNovember 12 - ETF Daily News |
 |
Pacific Biosciences of California Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagNovember 11 - Yahoo |
|
Pacific Biosciences of California (NASDAQ:PACB) Shares Gap Down – Here’s WhyNovember 9 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 40M | 30M | 10M | -61M | -57M | -0.220 |
| Q2 '24 | 36M | 30M | 5.9M | -173M | -169M | -0.640 |
| Q1 '24 | 39M | 28M | 11M | -78M | -68M | -0.290 |
| Q4 '23 | 58M | 49M | 9.6M | -82M | -68M | -0.310 |
| Q3 '23 | 56M | 38M | 18M | -67M | -73M | -0.260 |
Insider Transactions View All
| Kim Susan G. filed to sell 695,654 shares at $1.7. October 2 '24 |
| HENRY CHRISTIAN O filed to sell 2,497,763 shares at $1.7. September 17 '24 |
| Eidel Jeff filed to sell 869,730 shares at $1.6. August 20 '24 |
| Van Oene Mark filed to sell 1,630,815 shares at $1.7. August 20 '24 |
| Farmer Michele filed to sell 211,941 shares at $2. May 22 '24 |
Similar companies
Read more about Pacific Biosciences of California (PACB) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Pacific Biosciences of California?
The Market Cap of Pacific Biosciences of California is $471M.
What is the current stock price of Pacific Biosciences of California?
Currently, the price of one share of Pacific Biosciences of California stock is $1.80.
How can I analyze the PACB stock price chart for investment decisions?
The PACB stock price chart above provides a comprehensive visual representation of Pacific Biosciences of California's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Pacific Biosciences of California shares. Our platform offers an up-to-date PACB stock price chart, along with technical data analysis and alternative data insights.
Does PACB offer dividends to its shareholders?
As of our latest update, Pacific Biosciences of California (PACB) does not offer dividends to its shareholders. Investors interested in Pacific Biosciences of California should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Pacific Biosciences of California?
Some of the similar stocks of Pacific Biosciences of California are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
.